Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/29/2010 | CN101926791A Phospholipid complex of silybin dihemisuccinate disodium and preparation method and application thereof |
12/29/2010 | CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease |
12/29/2010 | CN101926787A Application of flavone compound in protecting liver |
12/29/2010 | CN101926781A Solid medicinal composition of oxapium iodide |
12/29/2010 | CN101926768A Fluticasone propionate foam agent composition |
12/29/2010 | CN101926767A Budesonide-foaming agent combination |
12/29/2010 | CN101926766A Ciclesonide foaming agent compound |
12/29/2010 | CN101926765A Fluticasone propionate foaming agent composition |
12/29/2010 | CN101926505A Caffeine electronic cigarette liquid |
12/29/2010 | CN101926396A Method for preparing Chinese medicinal bagged tea |
12/29/2010 | CN101658526B Veterinary compound enrofloxacin injection and preparation method thereof |
12/29/2010 | CN101632671B Suspensoid powder injection of piperacillin sodium sulbactam sodium medicine composition and novel application thereof |
12/29/2010 | CN101507792B Chinese patent medicine preparation capable of treating elderly constipation |
12/29/2010 | CN101468195B Chinese medicine preparation for gastritis and gastric ulcer |
12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
12/29/2010 | CN101428114B Medicament for treating chronic hepatitis B, cirrhosis and liver ascites |
12/29/2010 | CN101406668B Chinese medicinal composition for treating headache and dizzy, and preparation method thereof |
12/29/2010 | CN101385842B Medicine for treating chronic hepatitis b and preparation method thereof |
12/29/2010 | CN101380320B The use of cholinesterase inhibitors in pharmacy |
12/29/2010 | CN101347171B Freezing beverage containing chrysanthemum and method of preparing the same |
12/29/2010 | CN101327204B Use of emodic acid in preventing and treating fatty liver |
12/29/2010 | CN101306172B Traditional Chinese medicine for treating gingivitis and stomatocace |
12/29/2010 | CN101269184B Traditional Chinese medicine decoction for treating megrim |
12/29/2010 | CN101214309B Medicament for treating chronic colon/rectum mucous membrane inflammation |
12/29/2010 | CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
12/29/2010 | CN101168710B Eucommia bark wine and preparation method thereof |
12/29/2010 | CN101167805B Use of medicinal composition containing lotus leaves and hypericum japonicum total flavone extraction in preparing medicine for hepatitis B virus |
12/29/2010 | CN101130063B Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same |
12/29/2010 | CN101120784B Brain tonic food and preparation method thereof |
12/29/2010 | CN101098702B Drugs, food or drink for improving pancreatic functions |
12/29/2010 | CN101077110B Health-care tea and its making method |
12/29/2010 | CN101019598B Cold drink product capable of improving intestinal tract function |
12/29/2010 | CA2766524A1 Method for treating a patient in need of aspirin therapy |
12/29/2010 | CA2761921A1 Novel indole, indazole and benzimidazole arylamides |
12/28/2010 | USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
12/28/2010 | USRE42014 Pharmaceutical compositions |
12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
12/28/2010 | US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme |
12/28/2010 | US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
12/28/2010 | US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
12/23/2010 | WO2010148314A2 Preparation of esomeprazole and its pharmaceutically acceptable salts |
12/23/2010 | WO2010148234A1 Sap variants and their use |
12/23/2010 | WO2010147742A2 Use of nitrite salts in treating tissue damage |
12/23/2010 | WO2010147309A2 Pharmaceutical composition for preventing or treating inflammatory gastrointestinal disease comprising patchouli extract |
12/23/2010 | WO2010147234A1 Diarylamide-spirodiamine derivative |
12/23/2010 | WO2010147184A1 Prophylactic and/or therapeutic agent for dysmenorrhea |
12/23/2010 | WO2010147138A1 Gene encoding fatty acid elongase, and use thereof |
12/23/2010 | WO2010147133A1 Novel imidazopyridine compound |
12/23/2010 | WO2010147117A1 Peptide and use thereof |
12/23/2010 | WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor |
12/23/2010 | WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators |
12/23/2010 | WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof |
12/23/2010 | WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof |
12/23/2010 | WO2010145066A1 Compositions of sulfodehydroabietic acid disodium salt for preventing or treating hyperacid gastroenteritis and peptic ulcers and preparation methods thereof |
12/23/2010 | WO2010144959A1 Analogues of anti-fibrotic agents |
12/23/2010 | WO2010128312A3 Feed composition for the treatment or prevention of enteritis in fish |
12/23/2010 | WO2010049433A3 Water insoluble polymer: starch-based film coatings for colon targeting |
12/23/2010 | WO2009122252A3 Dental composition for treating peri-imlantitis |
12/23/2010 | US20100324134 Medicament for preventive and/or therapeutic treatment of bowel disease |
12/23/2010 | US20100324108 Substituted isoindoline-1,3-dione derivatives |
12/23/2010 | US20100324093 Ccr9 inhibitors and methods of use thereof |
12/23/2010 | US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS |
12/23/2010 | US20100324075 Therapeutic use of carboxyl ester lipase inhibitors |
12/23/2010 | US20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds |
12/23/2010 | US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists |
12/23/2010 | US20100324057 Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient |
12/23/2010 | US20100324056 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists |
12/23/2010 | US20100324051 Novel compounds as opioid receptor modulators |
12/23/2010 | US20100324050 Inhibitors of bruton's tyrosine kinase |
12/23/2010 | US20100324049 Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptor |
12/23/2010 | US20100324033 Oxadiazoanthracene compounds for the treatment of diabetes |
12/23/2010 | US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
12/23/2010 | US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
12/23/2010 | US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
12/23/2010 | US20100324001 Novel Methods for the Treatment of Inflammatory Diseases |
12/23/2010 | US20100323999 Therapeutic Molecules and Methods-1 |
12/23/2010 | US20100323990 Ship 1 modulator prodrugs |
12/23/2010 | US20100323964 New non-selective somatostatin analogues |
12/23/2010 | US20100323956 Glucose-regulating polypeptides and methods of making and using same |
12/23/2010 | US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer |
12/23/2010 | US20100323045 Extract formulation of opuntia ficus indica |
12/23/2010 | US20100323038 Pharmaceutical Compositions |
12/23/2010 | US20100323032 Agent for treating ulcer |
12/23/2010 | US20100323030 Composition with Anti-Inflammatory, Protein Synthesizing, Enzyme Deficiency Activating Genetic Therapy and Anti-Cancer Activity and Methods of Use |
12/23/2010 | US20100323012 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and Diuretics |
12/23/2010 | US20100323001 In Vivo Delivery Of Double Stranded RNA To a Target Cell |
12/23/2010 | US20100322964 Bacterial composition and its use |
12/23/2010 | US20100322955 Virulence genes, proteins, and their use |
12/23/2010 | US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same |
12/23/2010 | US20100322917 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
12/23/2010 | US20100322915 Protease Variants for Pharmaceutical Use |
12/23/2010 | US20100322912 Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients |
12/23/2010 | US20100322904 Composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
12/23/2010 | US20100322872 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
12/23/2010 | US20100322863 Methods and Uses of Anti-IL-23 Antibodies |
12/23/2010 | CA2801729A1 Compositions for and methods of activating guanylyl cyclase c |
12/23/2010 | CA2776883A1 Antimicrobial and antibiofilm activity of cathelicidins |
12/23/2010 | CA2765847A1 Prophylactic and/or therapeutic agent for dysmenorrhea |
12/23/2010 | CA2765577A1 Modulation of systemic exposure to rifaximin |
12/23/2010 | CA2765394A1 Sap variants and their use |